This presentation covers the role of radiation treatment in adult patients who have newly diagnosed glioblastoma, mostly focusing on external beam radiation therapy and its use today. This session outlines the standard-of-care radiotherapy protocols, including hypofractionation schedule.
The educational activity reviews foundational understanding of key resistance mechanisms, the strengths and weaknesses of preclinical models, and the advancements and setbacks of treatment response to radiotherapy, chemotherapy, and immunotherapy.
This program is designed to address the needs of a community practice physician and includes disease site reviews, interactive case-based discussions, a strategic dialogue with the ASTRO CEO and a radiation oncology practice overview.
This multi-session course provides a practical, evidence-based overview of contemporary palliative radiation oncology, with a focus on optimizing symptom relief, treatment selection, and supportive care for patients with advanced malignancies.
This activity explores the use of repeat radiation for intra-cranial neoplasms. Radiation is the primary management modality for the treatment of a number of intracranial pathologies and the initial treatment is well studied and relatively standardized across the specialty.
This presentation provides a review of workup, staging, and management of pediatric medulloblastomas and primitive neuroectodermal tumors (PNETs) including treatment planning considerations and future directions.
World Health Organization (WHO) grade 4 adult-type diffuse glioma remains one of the most challenging malignancies to treat, demanding a multidisciplinary and evidence-based approach.
The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.
This educational activity will help participants understand outcomes associated with the current treatment paradigm for high risk meningioma, as well as both the potential control benefits and toxicity concerns of dose-escalated postoperative radiation therapy.
The management of patients with brain metastases and leptomeningeal disease (LMD) presents complex clinical challenges requiring nuanced, evidence-based decision-making.